RothesteinPDornsbuschJBennettSA.Prolonged seizures associated with the use of viscous lidocaine.J Pediatr1982; 101: 461–3.
2.
MofensenHCCaraccioTRMillerHGreensherJ.Lidocaine toxicity from topical mucosal application.Clin Pediatr1983; 22: 190–2.
3.
GiardMJUdenDL.Seizures induced by oral viscous lidocaine (letter).ClinPharm1983; 2: 110.
4.
KarvonenSJokininKHollmenA.Arterial and venous blood lidocaine concentrations after local anesthesia of the respira-tory tract using an ultrasonic nebulizer.Acta Anaesth Scand1976; 20: 156–9.
5.
ChinnWMZavalaDCAmbreJ.Plasma levels of lidocaine following nebulized aerosol administration.Chest1977; 71: 346–8.
6.
JonesDAMcburneyAStanelyPJPlasma concentrations of lidocaine and its metabolites during fiberoptic bron-choscopy.Br J Anaesth1982; 54: 853–6.
7.
WeberG.Rotational brownian motion and polarization of the fluorescence of solutions.Adv Protein Chem1953; 8: 415–59.
8.
DandlikerWBDe SaussareVA.Fluorescence polarization in immunochemistry.Immunochemistry1970; 7: 799–828.
9.
DandlikerWBKellyRJDandlikerJFarquaharJLevinJ.Fluorescence polarization immunoassay; theory and experi-mental method.Immunochemistry1973; 10: 219–27.
10.
OlesKS.Pharmacokinetics in the aged. Part I: pharmacokinetic principles.Hasp Form1983; 18: 553–63.
11.
ResarRKWalsonPDFritzWLPerryDFBarbeeRA.Kinetics of theophylline: variability and effect of arterial pH in chronic obstructive lung disease.Chest1979; 76: 11–6.
